✦ LIBER ✦

UP-02.073 Treatment Outcomes of Oral Ethinylestradiol for Castration-Resistant Prostate Cancer, and Docetaxel for Relapsed Prostate Cancer After Treatment with Ethinylestradiol

✍ Scribed by T. Onita; K. Takehara; C. Ikeda; S. Maruta; Y. Shida; T. Kihara; T. Igawa; H. Sakai

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral etoposide and oral prednisone for t

✍ Zhu, Yi-Ping; Yao, Xu-Dong; Zhang, Shi-Lin; Dai, Bo; Zhang, Hai-Liang; Shen, Yi- 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 279 KB

UP-02.062 Clinical, Biochemical and Radi

✍ C. Casu; A. Rodriguez Antolin; D. Castellano; L. Anton Aparicio; J. Romero Otero 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Cost-Effectiveness Analysis of Abiratero

✍ Shibahara, H.; Shiroiwa, T.; Nakamura, K.; Shimozuma, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PCN66 Economic Evaluation of Abiraterone

✍ Persson, U.; Nilsson, S.; Hjortsberg, C.; Prûtz, C. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Treatment Decisions for Metastatic Castr

✍ Axel Heidenreich; David Pfister 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 232 KB

7028 Dasatinib and docetaxel combination

✍ Araujo, J.; Mathew, P.; Armstrong, A.J.; Braud, E.L.; Posadas, E.; Lonberg, M.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 55 KB